Learning Sequential Decisions from Multiple Sources via Group-Robust Markov Decision Processes
Organizations: Department of Statistics and Data Science, National University of Singapore · Department of Neurology, University of Pittsburgh · Department of Biostatistics, Harvard T.H. Chan School of Public Health · Department of Biomedical Informatics, Harvard Medical School ·
Abstract
Learning a common policy from multiple source environments requires accounting for cross-source heterogeneity, and the offline setting introduces an additional challenge of limited data coverage. We formulate this problem as a distributionally robust Markov decision process under a shared linear MDP representation with source-specific transition and reward components. The uncertainty set is constructed through feature-wise mixtures of these components, yielding a -rectangular structure that captures cross-source heterogeneity and admits a robust Bellman recursion. Building on this formulation, we develop Group-Robust Pessimistic Value Iteration (GR-PEVI), an offline policy-learning algorithm that combines feature-wise worst-case aggregation with a data-dependent pessimism penalty. Under a robust partial coverage condition, we establish finite-sample suboptimality guarantees for GR-PEVI and extend the analysis to clustered sources, characterizing the trade-off between the statistical gain from pooling similar sources and the approximation error induced by within-cluster heterogeneity. Simulation studies demonstrate the effectiveness of GR-PEVI, with empirical behavior consistent with the theoretical analysis. We apply GR-PEVI to a multi-source electronic health record study of multiple sclerosis treatment decisions to illustrate its use in a clinical setting.
Figures & tables
| Characteristic | Overall | MGB-young | MGB-old | UPMC |
|---|---|---|---|---|
| Patients, | 5,700 | 2,370 | 1,925 | 1,405 |
| Female sex, (%) | 4,244 (74.5%) | 1,750 (73.8%) | 1,398 (72.6%) | 1,096 (78.0%) |
| Age, mean (SD) | 40.9 (11.4) | 32.3 (6.5) | 51.3 (6.7) | 41.2 (11.0) |
| White race, (%) | 4,943 (86.9%) | 1,941 (81.9%) | 1,748 (90.8%) | 1,254 (90.0%) |
| Standard-efficacy DMT, (%) | 4,357 (76.4%) | 1,851 (78.1%) | 1,459 (75.8%) | 1,047 (74.5%) |
| High-efficacy DMT, (%) | 1,343 (23.6%) | 519 (21.9%) | 466 (24.2%) | 358 (25.5%) |
| Method | Mean | SD | Median | Win count | GR-PEVI win rate |
|---|---|---|---|---|---|
| GR-PEVI | 3.2042 | 0.0760 | 3.2107 | 30/50 | – |
| Operator-Avg PEVI | 3.1535 | 0.0803 | 3.1594 | 7/50 | 72% |
| Avg-PEVI | 3.1463 | 0.0814 | 3.1364 | 6/50 | 82% |
| Majority-PEVI | 3.1319 | 0.1050 | 3.1287 | 7/50 | 76% |
| Pooled PEVI | 3.0151 | 0.0803 | 3.0276 | 0/50 | 98% |
| Method | MGB-young | MGB-old | UPMC |
|---|---|---|---|
| GR-PEVI | (1.85) | (2.51) | (4.34) |
| Operator-Avg PEVI | (2.08) | (2.72) | (4.76) |
| Avg-PEVI | (2.10) | (2.98) | (5.58) |
| Majority-PEVI | (2.57) | (3.69) | (6.11) |
| Pooled PEVI | (2.18) | (2.25) | (3.30) |
| Method | Main setting | Milder transition heterogeneity |
|---|---|---|
| GR-PEVI | 0.017 (0.007) | 0.020 (0.006) |
| Pooled PEVI | 0.329 (0.042) | 0.274 (0.034) |
| Avg-PEVI | 0.951 (0.021) | 0.872 (0.020) |
| Majority-PEVI | 0.895 (0.022) | 0.778 (0.025) |
| Operator-Avg PEVI | 0.242 (0.021) | 0.196 (0.015) |
| Generic name | Brand name(s) | RxNorm ID |
| High efficacy | ||
| Natalizumab | Tysabri | 354770 |
| Ocrelizumab | Ocrevus | 1876366 |
| Ofatumumab | Arzerra; Kesimpta | 712566 |
| Mitoxantrone | Novantrone | 7005 |
| Alemtuzumab | Campath; Lemtrada | 117055 |
| Method | Mean | SD | Median | Win count | GR-PEVI win rate |
|---|---|---|---|---|---|
| GR-PEVI | 4.6629 | 0.0247 | 4.6576 | 38/50 | – |
| Operator-Avg PEVI | 4.6345 | 0.0128 | 4.6369 | 6/50 | 86% |
| Majority-PEVI | 4.6269 | 0.0237 | 4.6277 | 4/50 | 84% |
| Avg-PEVI | 4.6095 | 0.0348 | 4.6187 | 2/50 | 92% |
| Pooled PEVI | 4.3767 | 0.0577 | 4.3824 | 0/50 | 100% |
| Method | MICU/SICU | TSICU | SICU | MICU | CCU | CVICU |
|---|---|---|---|---|---|---|
| GR-PEVI | (0.65) | (0.89) | (0.71) | (0.55) | (0.59) | (0.62) |
| Operator-Avg PEVI | (0.25) | (0.45) | (0.39) | (0.24) | (0.79) | (0.30) |
| Avg-PEVI | (0.34) | (0.96) | (0.73) | (0.45) | (1.15) | (0.44) |
| Majority-PEVI | (0.28) | (0.68) | (0.51) | (0.31) | (0.83) | (0.31) |
| Pooled PEVI | (0.43) | (1.24) | (0.86) | (0.46) | (0.82) | (0.54) |
Robust Markov Decision Processes
Robust Markov decision processes optimize decisions under uncertain dynamics, seeking reliable performance against adverse transition models.
See all 27 papers